nsRPLND Appears Safe, Effective in Low-Volume Metastatic Seminoma
Nerve-sparing retroperitoneal lymph node dissection appears safe and effective for patients with low-volume metastatic seminoma.
Diagnosis & Disease Information
New Model Better Predicts Relapse in Stage I Seminoma
A new risk stratification model can identify patients with stage I seminoma who have a high risk of relapse, according to researchers.
Genitourinary Cancer Incidence and Mortality Varies by Region, Race, and Sex
Incidence and mortality rates for major genitourinary cancers differ according to sex, race/ethnicity, and geographic region.
Exercise Intervention During Chemotherapy Beneficial
Exercise during chemotherapy may preserve cardiorespiratory fitness, a study suggests.
Previous Cannabis Use Linked to Lower Risk of Some Genitourinary Cancers
A new study suggests that previous use of cannabis is associated with a lower risk of certain genitourinary cancers.
Late Relapse Is Rare in Testicular Cancer
Data suggest that 0.5% of patients with clinical stage I testicular cancer experience relapse after 10 years.
Modifiable AHOs Are Prognostic in Testicular Cancer Survivors
Modifiable adverse health outcomes affect overall mortality and cancer mortality in testicular cancer survivors.
Study Reveals Causes of Premature Death in Testicular Cancer Survivors
Certain treatments were associated with an increased risk of death unrelated to testicular cancer.
Uniform Care of Testicular Cancer Overcame Sociodemographic Factors
Guideline-directed care resulted in equivalent outcomes independent of hospital setting.
Long-Term AEs Persist in Some Survivors of Testicular Cancer
A subset of testicular cancer survivors experience persistent, treatment-related, long-term adverse health outcomes that affect their ability to work.
- Loading...
Loading...
Next post in Urologic Cancers
Loading... 
Loading...